These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16544673)

  • 1. Heparin dosing and therapeutic activated partial thromboplastin times (aPTT) in acute coronary syndrome (ACS).
    Westaway KP; Cruickshank M
    Aust Crit Care; 2006 Feb; 19(1):6-8, 10-4. PubMed ID: 16544673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
    Bauer SR; Ou NN; Dreesman BJ; Armon JJ; Anderson JA; Cha SS; Oyen LJ
    Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ineffectiveness of a non-weight based heparin regimen in achieving therapeutic activated partial thromboplastin time (aPTT) in acute coronary syndrome.
    Salamonson Y
    Aust Crit Care; 2000 Nov; 13(4):128-33. PubMed ID: 16948203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
    Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
    Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.
    Lee MS; Wali AU; Menon V; Berkowitz SD; Thompson TD; Califf RM; Topol EJ; Granger CB; Hochman JS
    J Thromb Thrombolysis; 2002 Oct; 14(2):91-101. PubMed ID: 12714828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a weight-based heparin nomogram for patients with acute coronary syndromes.
    Zimmermann AT; Jeffries WS; McElroy H; Horowitz JD
    Intern Med J; 2003; 33(1-2):18-25. PubMed ID: 12534874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
    Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
    Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of initial heparin infusion rates for a high-dose protocol.
    Smith A; Stock EM; Fewel N; Rose M; Griffiths CL
    J Thromb Thrombolysis; 2014 May; 37(4):419-26. PubMed ID: 23892474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a new target range for unfractionated heparin for acute coronary syndromes.
    Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS
    J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes.
    Mungall D; Lord M; Cason S; Treadwell P; Williams D; Tedrick D
    Am J Cardiol; 1998 Sep; 82(5):574-9. PubMed ID: 9732882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.
    Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P
    Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.
    Hosch LM; Breedlove EY; Scono LE; Knoderer CA
    Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gilchrist IC; Berkowitz SD; Thompson TD; Califf RM; Granger CB
    Am Heart J; 2002 Jul; 144(1):73-80. PubMed ID: 12094191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of heparin. Empiric vs nomogram-based dosing.
    Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
    Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Compliance with a Weight-based Nurse-driven Heparin Nomogram in a Tertiary Academic Medical Center.
    Schurr JW; Stevens CA; Bane A; Culbreth SE; Miller AL; Connors JM; Sylvester KW
    Crit Pathw Cardiol; 2018 Jun; 17(2):83-87. PubMed ID: 29768316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of heparin dosing based on adjusted body weight in obese patients.
    Fan J; John B; Tesdal E
    Am J Health Syst Pharm; 2016 Oct; 73(19):1512-22. PubMed ID: 27646813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest.
    Wahby KA; Jhajhria S; Dalal BD; Soubani AO
    Resuscitation; 2014 Apr; 85(4):533-7. PubMed ID: 24361456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of unfractionated heparin using activated partial thromboplastin time: an assessment of the current nomogram and analysis according to age.
    Kim JS; Lee HJ; Sung JD; Kim HJ; Lee SY; Kim JS
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):723-8. PubMed ID: 23615295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
    Raschke RA; Reilly BM; Guidry JR; Fontana JR; Srinivas S
    Ann Intern Med; 1993 Nov; 119(9):874-81. PubMed ID: 8214998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.